Eam Investors, LLC Corcept Therapeutics Inc Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $1.31 Million - $2.02 Million	59,809 New	59,809 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $1.35 Million - $1.59 Million	54,651 New	54,651 $1.4 Million
Q4 2017 Feb 12, 2018	SELL	$15.77 - $20.72 $1.14 Million - $1.5 Million	-72,542 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$12.3 - $19.3 $892,266 - $1.4 Million	72,542	72,542 $1.4 Million

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.